Brigitte Autran

Active 1983–2025

108
Papers
18,669
Citations
83
h-index
104
i10-index

Citations

Citations per year for Brigitte Autran1983: 1 citations1984: 1 citations1985: 2 citations1986: 3 citations1987: 2 citations1988: 14 citations1989: 25 citations1990: 27 citations1991: 39 citations1992: 27 citations1993: 31 citations1994: 38 citations1995: 31 citations1996: 39 citations1997: 61 citations1998: 110 citations1999: 170 citations2000: 155 citations2001: 159 citations2002: 127 citations2003: 114 citations2004: 113 citations2005: 138 citations2006: 84 citations2007: 105 citations2008: 130 citations2009: 113 citations2010: 131 citations2011: 151 citations2012: 136 citations2013: 144 citations2014: 143 citations2015: 136 citations2016: 130 citations2017: 95 citations2018: 90 citations2019: 433 citations2020: 374 citations2021: 467 citations2022: 331 citations2023: 176 citations2024: 227 citations2025: 118 citations2026: 4 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,085 citing papers, 29.3% of this breakdownFrance: 623 citing papers, 8.8% of this breakdownUnited Kingdom: 516 citing papers, 7.3% of this breakdownGermany: 307 citing papers, 4.3% of this breakdownItaly: 300 citing papers, 4.2% of this breakdownAustralia: 276 citing papers, 3.9% of this breakdownChina: 259 citing papers, 3.6% of this breakdownCanada: 241 citing papers, 3.4% of this breakdownNetherlands: 204 citing papers, 2.9% of this breakdownSpain: 201 citing papers, 2.8% of this breakdownSouth Africa: 156 citing papers, 2.2% of this breakdownSwitzerland: 154 citing papers, 2.2% of this breakdown
0%29.3%Other 25.1%

Fields

  • Medicine44.4%
  • Immunology and Microbiology44.3%
  • Biochemistry, Genetics and Molecular Biology4.8%
  • Pharmacology, Toxicology and Pharmaceutics2%
  • Neuroscience0.9%
  • Engineering0.9%
  • Other2.7%

Topics

  • HIV Research and Treatment13.8%
  • Immune Cell Function and Interaction7.9%
  • HIV/AIDS Research and Interventions5.5%
  • HIV/AIDS drug development and treatment4.7%
  • T-cell and B-cell Immunology4.3%
  • Cytomegalovirus and herpesvirus research3.5%
  • Other60.3%

Coauthors

All papers

Open in search
  1. Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , - PLoS Pathogens 2013 cited by 998

  2. Persistent Chronic Inflammation and Infection by Chikungunya Arthritogenic Alphavirus in Spite of a Robust Host Immune Response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Immunology 2010 cited by 628

  3. HIV

    Authors: , , , , - The Lancet 2018 cited by 312

  4. Sex Differences in Plasmacytoid Dendritic Cell Levels of IRF5 Drive Higher IFN-α Production in Women

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Immunology 2015 cited by 248

  5. Reduced Oxidative Burst by Primed Neutrophils in the Elderly Individuals Is Associated With Increased Levels of the CD16bright/CD62LdimImmunosuppressive Subset

    Authors: , , , , , , , , - The Journals of Gerontology Series A 2016 cited by 79

  6. 40nm, but not 750 or 1,500nm, Nanoparticles Enter Epidermal CD1a+ Cells after Transcutaneous Application on Human Skin

    Authors: , , , , , , , , - Journal of Investigative Dermatology 2006 cited by 383

  7. Positive Effects of Combined Antiretroviral Therapy on CD4 + T Cell Homeostasis and Function in Advanced HIV Disease

    Authors: , , , , , , , , - Science 1997 cited by 1,806

  8. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover

    Authors: , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2007 cited by 715

  9. SARS-CoV-2 variants and ending the COVID-19 pandemic

    Authors: , , , , , - The Lancet 2021 cited by 572

  10. CAR T-cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Haematologica 2023 cited by 25

  11. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies

    Authors: , , , , , , , , , - BMC Infectious Diseases 2009 cited by 133

  12. Ultra-Protective Ventilation Reduces Biotrauma in Patients on Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome*

    Authors: , , , , , , , , , , - Critical Care Medicine 2019 cited by 143

  13. International AIDS Society global scientific strategy: towards an HIV cure 2016

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cynthia Grossman, Gail E. Henderson, Timothy J. Henrich, Richard Jefferys, Hans-Peter Kiem, Joseph McCune, Keymanthri Moodley, Peter A. Newman, Monique Nijhuis, Moses Supercharger Nsubuga, Melanie Ott, Sarah Palmer, Douglas D. Richman, Asier Sáez‐Cirión, Matthew Sharp, Janet D. Siliciano, Guido Silvestri, Jerome Amir Singh, Bruno Spire, Jeffrey Taylor, Martin Tolstrup, Susana Valente, Jan van Lunzen, Rochelle P. Walensky, Ira Wilson, Jerome A. Zack - Nature Medicine 2016 cited by 422

  14. Rapid Progression to AIDS in HIV + Individuals with a Structural Variant of the Chemokine Receptor CX 3 CR1

    Authors: , , , , , , , , , , , , , , - Science 2000 cited by 329

  15. Identifying Cytomegalovirus Complications Using the Quantiferon-CMV Assay After Allogeneic Hematopoietic Stem Cell Transplantation

    Authors: , , , , , , , , , , , - The Journal of Infectious Diseases 2017 cited by 84

  16. Distinct immunopathological mechanisms of EBV-positive and EBV-negative posttransplant lymphoproliferative disorders

    Authors: , , , , , , , , , , , , , , - American Journal of Transplantation 2021 cited by 25

  17. Cytofluorometric methods for assessing absolute numbers of cell subsets in blood

    Authors: , , , , , , , , , , , , , , - Cytometry 2000 cited by 229

  18. Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Cells 2022 cited by 25

  19. Clonal succession after prolonged antiretroviral therapy rejuvenates CD8+ T cell responses against HIV-1

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2024 cited by 15

  20. A truncated HIV Tat demonstrates potent and specific latency reversal activity

    Authors: , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2023 cited by 15

  21. Drastic decrease of the HIV reservoir in a patient treated with nivolumab for lung cancer

    Authors: , , , , , , - Annals of Oncology 2017 cited by 160

  22. Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thierry Allègre, Alain Lafeuillade, Gilles Hittinger, Véronique Lambry, M. Carrerre, G. Stevenson Philip, Claudine Duvivier, Paul‐Henri Consigny, Caroline Charlier, Maryam Shoai, F. Touam, G. Pialoux, Laurence Slama, Thomas L’Yavanc, Philippe Mathurin, Asma Adda, V Berrebi, Dominique Salmon, E. Chakvetadze, T. Tassadit, E. Ousseima, M P Pietri, Yaniv Levy, Anne Sophie Lascaux, Jean‐Daniel Lelièvre, M. Giovanna, S. Dominguez, Clément Dumont, Christine Katlama, M. A. Valentin, Sophie Seang, Lars Schneider, N. Kiorza, Aziza Chermak, Saoussen Ben Abdallah, Anne Simon, F. Pichon, Michèle Pauchard, Jean‐Michel Molina, C. Lascoux, Diane Ponscarme, Nathalie Verdière, Anne Scemla, N. De Castro, A. Rachline, Valérie Garrait, W. Rozenbaum, Samuel Ferret, Suna Balkan, F Clavel, Mathieu Tourdjman, Matthieu Lafaurie, Alexandre Aslan, Jérôme Goguel, S. Thierry, Victoire de Lastours, S. Gallien, J. Pavie, Jonathan Delgado, C. Mededji, R. Verón, S. Abel, S. Pierre-François, C. Baringhton, J.M. Chennebault, Yves-Marie Vandamme, P Fialaire, Sami Rehaiem, V. Rabier, P. Abgueguen and 130 more - Journal of Antimicrobial Chemotherapy 2015 cited by 103

  23. Treatment interruption in chronically HIV-infected patients with an ultralow HIV reservoir

    Authors: , , , , , , , , , , , - AIDS 2016 cited by 82

  24. Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?

    Authors: , , , , , , , - AIDS 2019 cited by 37